7 terminated. 7 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Terminated 7 |
| Phase 2 | 3 | Terminated 3 |
Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria artemether:lumefantrine (2.5 mg:30 mg) - Plasmodium Falciparum Malaria | Phase 2 / Phase 3 | Terminated | Novartis Pharmaceuticals | 28 | 2020-12-21 | 2026-01-13 |
| Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia Dihydroartemisinin-piperaquine (DHAP) administered to G6PD deficient, Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD deficient, Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD deficient - Malaria | Phase 2 / Phase 3 | Terminated | London School of Hygiene and Tropical Medicine | 61 | 2015-12-01 | 2016-09-09 |
| The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzania abamectin and fenpyroximate - Malaria | Phase 3 | Terminated | National Institute for Medical Research, Tanzania | 4917 | 2015-11-09 | 2019-02-05 |
| Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy Cotrimoxazole, Sulfadoxine-pyrimethamine - Malaria in Pregnancy | Phase 3 | Terminated | Institute of Tropical Medicine, Belgium | 352 | 2009-02-01 | 2016-01-18 |
| Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria Pyronaridine - artesunate, Chloroquine - Malaria | Phase 3 | Terminated | Medicines for Malaria Venture | 30 | 2007-09-06 | 2022-01-26 |
| IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria. sulphadoxine/pyrimethamine, Chlorproguanil/dapsone, Sulfadoxine/pyrimethamine - Malaria | Phase 3 | Terminated | London School of Hygiene and Tropical Medicine | 112 | 2006-07-01 | 2017-01-26 |
| Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia Azithromycin/Chloroquine, Sulfadoxine-Pyrimethamine/Chloroquine - Malaria, Falciparum | Phase 2 / Phase 3 | Terminated | Pfizer | 32 | 2004-03-01 | 2008-11-03 |
Malaria, Falciparum (2) · Malaria, Vivax (1)
Infections (7) · Mosquito-Borne Diseases (7) · Parasitic Diseases (7) · Protozoan Infections (7) · Vector Borne Diseases (7)
fanasil, pyrimethamine drug combination (3) · Chloroquine (2) · Azithromycin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · abamectin (1) · chloroguanil, dapsone drug combination (1) · fenpyroximate (1) · pyronaridine tetraphosphate, artesunate drug combination (1)
London School of Hygiene and Tropical Medicine (2) · Institute of Tropical Medicine, Belgium (1) · Medicines for Malaria Venture (1) · National Institute for Medical Research, Tanzania (1) · Novartis Pharmaceuticals (1) · Pfizer (1)
Tanzania (2) · Burkina Faso (1) · Democratic Republic of the Congo (1) · South Korea (1) · The Gambia (1) · Zambia (1)
Christine Manyando, MD (1) · Jaqueline Mosha, MD (1) · Joseph P Mugasa, PhD (1) · Roly D Gosling, MD (1) · Samwel Gesase, MD (1) · Stephan Duparc, MD (1) · William N Kisinza, PhD (1)
PMID 19238219, PMID 24830749, PMID 27456339, PMID 29324864, PMID 34521374, PMID 39324693, PMID 41199347